What is the price target for MRVL stock?
50 analysts have analysed MRVL and the average price target is 120.99 USD. This implies a price increase of 1.3% is expected in the next year compared to the current price of 119.43.
NASDAQ:MRVL • US5738741041
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MARVELL TECHNOLOGY INC (MRVL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-09 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2026-04-09 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2026-03-31 | Benchmark | Reiterate | Buy -> Buy |
| 2026-03-06 | TD Cowen | Maintains | Hold -> Hold |
| 2026-03-06 | KGI Securities | Upgrade | Neutral -> Outperform |
| 2026-03-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-03-06 | Benchmark | Upgrade | Hold -> Buy |
| 2026-03-06 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-03-06 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2026-03-06 | Stifel | Maintains | Buy -> Buy |
| 2026-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-03-06 | B of A Securities | Upgrade | Neutral -> Buy |
| 2026-03-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-06 | Craig-Hallum | Maintains | Buy -> Buy |
| 2026-03-06 | Citigroup | Maintains | Buy -> Buy |
| 2026-03-04 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-03-02 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-23 | UBS | Maintains | Buy -> Buy |
| 2026-02-17 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2026-02-03 | UBS | Maintains | Buy -> Buy |
| 2026-02-03 | Needham | Maintains | Buy -> Buy |
| 2026-02-03 | Benchmark | Reiterate | Hold -> Hold |
| 2026-02-03 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-02-03 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-15 | RBC Capital | Initiate | Outperform |
| 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.508B -6.96% | 5.767B 4.71% | 8.195B 42.09% | 10.194B 24.40% | 13.304B 30.51% | 18.428B 38.51% | 19.902B 8.00% | 22.121B 11.15% | 24.217B 9.48% | 26.435B 9.16% | 28.866B 9.20% | |
| EBITDA YoY % growth | 961.1M -48.38% | 990.5M 3.06% | 2.63B 165.47% | 3.979B 51.32% | 5.179B 30.16% | 7.245B 39.89% | 7.422B 2.44% | 8.082B 8.89% | 8.869B 9.74% | N/A | N/A | |
| EBIT YoY % growth | -436.6M -193.01% | -366.4M 16.08% | 1.339B 465.42% | 3.621B 170.45% | 5.022B 38.69% | 6.477B 28.97% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -7.93% | -6.35% | 16.34% | 35.52% | 37.75% | 35.15% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 1.51 -28.77% | 1.57 3.97% | N/A 83.83% | 3.46 19.75% | 4.82 39.41% | 6.57 36.31% | 9.04 37.60% | 10.39 15.01% | 11.79 13.44% | 13.31 12.89% | 15.09 13.33% |
All data in USD
| Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | Q1 / 29 | Q2 / 29 | Q3 / 29 | Q4 / 29 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.82 31.62% | 0.92 37.55% | 1.03 35.51% | 1.15 43.19% | 1.20 47.64% | 1.32 43.16% | 1.46 41.84% | 1.63 42.53% | 1.70 41.17% | 1.84 39.35% | 1.98 35.64% | 2.11 29.01% |
| Revenue Q2Q % growth | 2.447B 29.11% | 2.64B 31.60% | 2.869B 38.30% | 3.116B 40.44% | 3.307B 35.15% | 3.58B 35.61% | 3.921B 36.67% | 4.318B 38.58% | 4.502B 36.14% | 4.788B 33.74% | 5.091B 29.84% | 5.342B 23.71% |
| EBITDA Q2Q % growth | 881.42M 49.85% | 992.4M 3.75% | 1.1B -18.00% | 1.208B -29.13% | 1.395B 58.27% | 1.537B 54.88% | 1.695B 54.09% | 1.857B 53.73% | 1.68B 20.43% | 1.818B 18.28% | 1.961B 15.69% | 2.098B 12.98% |
| EBIT Q2Q % growth | 830.02M 221.34% | 930.06M 211.27% | 1.034B 181.05% | 1.163B 180.99% | 1.204B 45.06% | 1.318B 41.71% | 1.473B 42.46% | 1.66B 42.73% | 1.635B 35.80% | 1.759B 33.46% | 1.893B 28.51% | 2.019B 21.63% |
All data in USD
50 analysts have analysed MRVL and the average price target is 120.99 USD. This implies a price increase of 1.3% is expected in the next year compared to the current price of 119.43.
MARVELL TECHNOLOGY INC (MRVL) will report earnings on 2026-05-27.
The consensus EPS estimate for the next earnings of MARVELL TECHNOLOGY INC (MRVL) is 0.82 USD and the consensus revenue estimate is 2.45B USD.
The consensus rating for MARVELL TECHNOLOGY INC (MRVL) is 81.6 / 100 . This indicates that analysts generally have a positive outlook on the stock.